I'm picking up what you're putting down about Dominique Levin's take on applying the #Winning #by #Design model to pharma. Here's the tea ☕️... The frustration is totally valid! When we're talking pharma sales, we're not just dealing with any B2B model - we're diving into one of the most complex, regulated, and nuanced sectors out there. Just saying "HCPs are doctors" is like saying "water is wet" - it doesn't move the needle! What's missing here? The REAL pharma insider perspective! 📊 You're absolutely right about needing to tap into the existing knowledge base: Commercial heads who've been in the trenches Sales force leaders who know the HCP engagement playbook Regional managers who understand territory dynamics Here's what makes this conversation so important: Pharma sales isn't just another B2B vertical - it's its own ecosystem with: Complex stakeholder networks Regulatory frameworks that change the whole game Decision-making processes that don't fit neat little boxes Here is how this melts down into data: According to McKinsey & Company's 2023 report "The Future of Pharma Sales": 75% of #HCPs prefer hybrid engagement models Digital-first engagement has jumped 3x since 2019 Only 20% of traditional sales calls result in meaningful HCP interactions Why This Matters for the Winning by Design Conversation 🎯 Market Size & Complexity Global pharma sales: $1.48 trillion (2022) Average pharma sales cycle: 12-18 months Stakeholder map includes average of 6.8 decision makers (Source: IQVIA Institute, 2023) The Real Tea on Pharma Sales Models ☕️ Traditional models aren't cutting it anymore! Check these stats: 65% of #HCPs restrict or limit sales rep access 80% want personalized scientific content 73% expect omnichannel engagement (Accenture Healthcare Provider Survey, 2023) Personal Hot Take 🌶️ When I see generic #B2B frameworks being force-fed into #pharma without the nuance... I just can't! 😤 It's like trying to fit a square peg in a round hole while wearing a blindfold and spinning! The Missing Pieces That Matter: Regulatory compliance (hello, #Sunshine #Act!) Medical-legal review processes KOL relationship management Formulary acceptance cycles Real Talk: Success Stories 📈 Companies that got it right: Novartis: 40% increase in #HCP engagement through AI-powered targeting GSK: 3x improvement in rep productivity with hybrid model Merck: 55% better KOL relationship scores with integrated approach (Veeva CRM Engagement Data, 2023) #PharmaInnovation #SalesTransformation #HealthcareTech The Bottom Line 💫 Before dropping frameworks into pharma, we need to: Study the ecosystem Talk to the veterans Understand the compliance landscape Map the REAL stakeholder journey